Physician Internal Medicine, Medical Oncology, Medical Oncologist - OUTPATIENT ONLY (Open Rank/Track Faculty)

Position Overview

The Ohio State University College of Medicine and the Wexner Medical Center seek a Medical Oncologist to join the Department of Internal Medicine, Division of Medical Oncology. The position will have a 70/30 split of appointment, focusing 70% of time in outpatient clinic.

Requirements

• Medical Doctor (MD) or Doctor of Osteopathic Medicine (DO)
• Completion of accredited Oncology/Hematology Fellowship
• Board Certified in Internal Medicine and board eligible or certified in Medical Oncology
• Able to meet medical licensure requirements in Ohio
• Active certification from the Drug Enforcement Administration (DEA) required

Qualifications

High priority searches at this time are those who desire to focus their research and patient care in Medical Oncology. Features include:

• NCI-designated Comprehensive Cancer Center since 1976
• One of only 11 freestanding cancer hospitals in the U.S.
• Magnet® designation
• One of only four cancer centers funded by the NCI to conduct Phase I and II cancer clinical trials
• Founding member of the National Comprehensive Cancer Network (NCCN)
• Founding member of the Oncology Research Information Exchange Network (ORIEN)
• Robust clinical trials program with active translational therapeutics that include a clinical research unit, Phase 1 U01 grant and N01 Phase II contract
• Consistently ranked as one of America’s Best Cancer Hospitals by U.S. News & World Report
• Financially-secure program with strong philanthropic and community support

Benefits

Features include:

• NCI-designated Comprehensive Cancer Center since 1976
• One of only 11 freestanding cancer hospitals in the U.S.
• Magnet® designation
• One of only four cancer centers funded by the NCI to conduct Phase I and II cancer clinical trials
• Founding member of the National Comprehensive Cancer Network (NCCN)
• Founding member of the Oncology Research Information Exchange Network (ORIEN)
• Robust clinical trials program with active translational therapeutics that include a clinical research unit, Phase 1 U01 grant and N01 Phase II contract
• Consistently ranked as one of America’s Best Cancer Hospitals by U.S. News & World Report
• Financially-secure program with strong philanthropic and community support